Regeneron's 2025 outlook includes defensive capital allocation, competitive pressure on Eylea, et cetera. Click here to read ...

Regeneron Pharmaceuticals Inc (REGN) reports robust financial performance with a 10% revenue increase and unveils new ...

A treatment for patients living with advanced non-small cell lung cancer (NSCLC) who failed two or more standard-of-care (SOC) options could extend overall survival (OS) to 16.9 months according to ...

Moments after Regeneron CEO Len Schleifer scolded analysts for asking too many questions about the disappointing sales of eye ...

MAIA Biotechnology, Inc., ("MAIA", the "Company"), a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer, today announced positive updated data from its THIO-101 ...

Biotech giant Regeneron Pharmaceuticals, Inc. REGN is slated to report fourth-quarter and full-year 2024 results on Feb. 4, ...

TD Cowen adjusted its outlook on Regeneron Pharmaceuticals, with analyst Tyler Van Buren revising the price target to $1,030 ...

Positive News is the media brand for rigorous journalism about what’s going right. We report socially relevant and uplifting stories of progress – ranging from the global boom in renewable energy to ...

Police figures obtained by road safety charity IAM RoadSmart indicate 51% of tests were positive in 2023, and 49% were positive in the first seven months of last year. This is based on data provided ...

Credit growth is significantly below industry growth and margins are likely to remain stable QoQ with a slight positive bias,” said Axis Securities in a report. Brokerages have slashed target ...

Mélanie Brochu, a forensic specialist in the RCMP's trace evidence services, said swabs taken from Zakkary Reed within hours of the shooting tested positive for gunshot residue. Reed ...

Northern Star reports record first-half cash flow due to a strong operational performance and high gold prices. The Northern Star share price opened 1.18% lower at $16.79 per share, then rose to ...